According to Imunon's latest financial reports the company's current EPS (TTM) is -$3.77. In 2022 the company made an earnings per share (EPS) of -$5.17 an increase over its 2021 EPS that were of -$5.91.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.77 | -27.08% |
2022 | -$5.17 | -12.52% |
2021 | -$5.91 | -41.4% |
2020 | -$10.08 | -11.53% |
2019 | -$11.40 | 16.92% |
2018 | -$9.75 | -86.6% |
2017 | -$72.76 | -58.99% |
2016 | -$177.45 | -19.52% |
2015 | -$220.50 | -23.36% |
2014 | -$287.70 | 35.64% |
2013 | -$212.10 | -70.6% |
2012 | -$721.35 | -32.51% |
2011 | -$1,069 | -25.58% |
2010 | -$1,436 | 6.29% |
2009 | -$1,351 | 23.28% |
2008 | -$1,096 | -135.37% |
2007 | $3,100 | -561.97% |
2006 | -$670.94 | -12.35% |
2005 | -$765.44 | -38.64% |
2004 | -$1,247 | -26.67% |
2003 | -$1,701 | 9.09% |
2002 | -$1,559 | 10% |
2001 | -$1,417 |